Literature DB >> 11928843

High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases.

F Nayeri1, I Nilsson, L Brudin, A Fryden, C Söderström, P Forsberg.   

Abstract

Acute serum levels of hepatocyte growth factor (HGF) were studied in 6 clinical groups with (i) gastroenteritis, (ii) skin and soft tissue infection, (iii) urinary tract infection, (iv) septicemia, (v) influenza, and (vi) chronic hepatitis C in comparison with a normal control group using an enzyme-linked immunosorbent assay method. We found that serum HGF levels were significantly higher in patients with acute infectious diseases (p < 0.0001) compared to patients with chronic viral hepatitis and healthy controls. Serum HGF and CRP levels were correlated significantly (r=0.65, p < 10(-7)). We conclude that serum HGF levels are elevated in patients with acute infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11928843     DOI: 10.1080/00365540110077236

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C.

Authors:  Panasiuk Anatol; Flisiak Robert; Prokopowicz Danuta
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

Review 2.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

3.  Improvement of sepsis by hepatocyte growth factor, an anti-inflammatory regulator: emerging insights and therapeutic potential.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

4.  Hepatocyte growth factor (HGF) in fecal samples: rapid detection by surface plasmon resonance.

Authors:  Fariba Nayeri; Daniel Aili; Tayeb Nayeri; Junyang Xu; Sven Almer; Ingemar Lundström; Britt Akerlind; Bo Liedberg
Journal:  BMC Gastroenterol       Date:  2005-04-12       Impact factor: 3.067

5.  Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis.

Authors:  Amir Ramezani; Katarina Nägga; Oskar Hansson; Johanna Lönn; Johanna Sjöwall; Fateme Katoozian; Sepahdar Mansouri; Fariba Nayeri
Journal:  Fluids Barriers CNS       Date:  2015-09-25

6.  Clinical impact of real-time evaluation of the biological activity and degradation of hepatocyte growth factor.

Authors:  Fariba Nayeri; Tayeb Nayeri; Daniel Aili; Lars Brudin; Bo Liedberg
Journal:  Growth Factors       Date:  2008-06       Impact factor: 2.511

7.  Proinflammatory Cytokines (IL-1α, IL-6) and Hepatocyte Growth Factor in Patients with Alcoholic Liver Cirrhosis.

Authors:  Andrzej Prystupa; Paweł Kiciński; Jarosław Sak; Anna Boguszewska-Czubara; Anna Toruń-Jurkowska; Wojciech Załuska
Journal:  Gastroenterol Res Pract       Date:  2015-08-20       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.